CAMK2G and familial dilated cardiomyopathy: Although there are several studies of RIPK3 inhibition (GSK’872) during I/R injury (273) and cardiac fibrosis (274)/hypertrophy (275) via CaMKII pathway, there are no record on DCM yet.